Ronald Chen: What Role Does MK2 Play in Head and Neck Cancer Progression?
Ronald Chen/LinkedIn

Ronald Chen: What Role Does MK2 Play in Head and Neck Cancer Progression?

Ronald Chen, Chair of Radiation Oncology at the University of Kansas Medical Center, shared on LinkedIn:

“There’s some incredible research being done around the protein MK2 and how it contributes to the spread of cancer, and in particular head and neck cancers.

I had the chance to hear more about this research from radiation oncologist and physician-scientist Dr. Gregory Gan at The University of Kansas Cancer Center’s Research Symposium earlier this month.

Dr. Gan’s lab has done fantastic work expanding our understanding of how MK2 functions in head and neck cancer. And now, his lab is working on therapies that can help block it (and thus reduce cancer spread).

The University of Kansas Cancer Center’s annual research symposium is where staff and physicians, like myself, learn more about the cancer center’s research initiatives and progress.

We had ten speakers, including national experts, internal experts, and trainees. We also heard from our Vice Chancellor and Cancer Center Director, Dr. Roy Jensen.

There were breakout sessions, a trainee poster competition (where over 85 posters were presented!) and a ton of organic networking. Over $335K in funding was awarded for pilot projects!

This symposium is an opportunity for all of us to collaborate, discuss and learn together – all in the name of improving cancer care.

The annual The University of Kansas Cancer Center research symposium is always so energizing, and leaves attendees with hope. We are making progress in our fight against cancer, and making an impact in our region and beyond.”

Ronald Chen: What Role Does MK2 Play in Head and Neck Cancer Progression?

You can also read: After a Decade Without a New Option, FDA Approves Amivantamab for Head and Neck Cancer

Ronald Chen: What Role Does MK2 Play in Head and Neck Cancer Progression?